These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 34285711)
21. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance. Ferrara F; Vitiello A Cardiovasc Toxicol; 2021 Jun; 21(6):498-503. PubMed ID: 33835386 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019. Suh SH; Ma SK; Kim SW; Bae EH Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712 [TBL] [Abstract][Full Text] [Related]
23. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus. Xu J; Lazartigues E Cell Mol Neurobiol; 2022 Jan; 42(1):305-309. PubMed ID: 32623546 [TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540 [TBL] [Abstract][Full Text] [Related]
25. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19. Pedrosa MA; Valenzuela R; Garrido-Gil P; Labandeira CM; Navarro G; Franco R; Labandeira-Garcia JL; Rodriguez-Perez AI Clin Sci (Lond); 2021 Feb; 135(3):465-481. PubMed ID: 33479758 [TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems. Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210 [TBL] [Abstract][Full Text] [Related]
27. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? Nicolau LAD; Magalhães PJC; Vale ML Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin II receptors: Impact for COVID-19 severity. Aksoy H; Karadag AS; Wollina U Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19). Nayak SK Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074 [TBL] [Abstract][Full Text] [Related]
30. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections. Ferrara F; Vitiello A Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1589-1593. PubMed ID: 34151392 [TBL] [Abstract][Full Text] [Related]
31. "Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry. Shukla SP; Cho KB; Rustagi V; Gao X; Fu X; Zhang SX; Guo B; Udugamasooriya DG Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445669 [TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic. Perico L; Benigni A; Remuzzi G Curr Opin Nephrol Hypertens; 2021 Mar; 30(2):252-263. PubMed ID: 33395036 [TBL] [Abstract][Full Text] [Related]
33. Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19. Sarver DC; Wong GW Biochem Biophys Res Commun; 2021 Jan; 538():92-96. PubMed ID: 33168188 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies. Pathangey G; Fadadu PP; Hospodar AR; Abbas AE Am J Physiol Lung Cell Mol Physiol; 2021 Mar; 320(3):L301-L330. PubMed ID: 33237815 [TBL] [Abstract][Full Text] [Related]
35. Advances in research on ACE2 as a receptor for 2019-nCoV. Wu J; Deng W; Li S; Yang X Cell Mol Life Sci; 2021 Jan; 78(2):531-544. PubMed ID: 32780149 [TBL] [Abstract][Full Text] [Related]
36. Population-Specific Hashizume M; Gonzalez G; Ono C; Takashima A; Iwasaki M Viruses; 2021 Jan; 13(1):. PubMed ID: 33418950 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells. Verma D; Church TM; Swaminathan S J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968 [TBL] [Abstract][Full Text] [Related]
38. Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19? Li J; Yan Y; Dou F; Gao J Biosci Trends; 2022; 16(6):459-461. PubMed ID: 36567123 [TBL] [Abstract][Full Text] [Related]
39. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression. Zlacká J; Stebelová K; Zeman M; Herichová I Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351 [TBL] [Abstract][Full Text] [Related]
40. Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells. Almeida-da-Silva CLC; Matshik Dakafay H; Liu K; Ojcius DM Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]